NCT05392205View on ClinicalTrials.gov

Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Tumor, SolidPositron-Emission Tomography
Interventions
DIAGNOSTIC_TEST

18F-FDG

Each subject receives a single intravenous injection of 18F-FDG and 68Ga-FAP-2286, and undergo PET/CT imaging within the specified time. A part of participants will also undergo additional 68Ga-FAPI-46 PET/CT for comparison.

Trial Locations (1)

361000

The First affiliated hospital of xiamen university, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER